ZEB1_HUMAN - dbPTM
ZEB1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ZEB1_HUMAN
UniProt AC P37275
Protein Name Zinc finger E-box-binding homeobox 1
Gene Name ZEB1
Organism Homo sapiens (Human).
Sequence Length 1124
Subcellular Localization Nucleus .
Protein Description Acts as a transcriptional repressor. Inhibits interleukin-2 (IL-2) gene expression. Enhances or represses the promoter activity of the ATP1A1 gene depending on the quantity of cDNA and on the cell type. Represses E-cadherin promoter and induces an epithelial-mesenchymal transition (EMT) by recruiting SMARCA4/BRG1. Represses BCL6 transcription in the presence of the corepressor CTBP1. Positively regulates neuronal differentiation. Represses RCOR1 transcription activation during neurogenesis. Represses transcription by binding to the E box (5'-CANNTG-3'). Promotes tumorigenicity by repressing stemness-inhibiting microRNAs..
Protein Sequence MADGPRCKRRKQANPRRNNVTNYNTVVETNSDSDDEDKLHIVEEESVTDAADCEGVPEDDLPTDQTVLPGRSSEREGNAKNCWEDDRKEGQEILGPEAQADEAGCTVKDDECESDAENEQNHDPNVEEFLQQQDTAVIFPEAPEEDQRQGTPEASGHDENGTPDAFSQLLTCPYCDRGYKRFTSLKEHIKYRHEKNEDNFSCSLCSYTFAYRTQLERHMTSHKSGRDQRHVTQSGCNRKFKCTECGKAFKYKHHLKEHLRIHSGEKPYECPNCKKRFSHSGSYSSHISSKKCISLIPVNGRPRTGLKTSQCSSPSLSASPGSPTRPQIRQKIENKPLQEQLSVNQIKTEPVDYEFKPIVVASGINCSTPLQNGVFTGGGPLQATSSPQGMVQAVVLPTVGLVSPISINLSDIQNVLKVAVDGNVIRQVLENNQANLASKEQETINASPIQQGGHSVISAISLPLVDQDGTTKIIINYSLEQPSQLQVVPQNLKKENPVATNSCKSEKLPEDLTVKSEKDKSFEGGVNDSTCLLCDDCPGDINALPELKHYDLKQPTQPPPLPAAEAEKPESSVSSATGDGNLSPSQPPLKNLLSLLKAYYALNAQPSAEELSKIADSVNLPLDVVKKWFEKMQAGQISVQSSEPSSPEPGKVNIPAKNNDQPQSANANEPQDSTVNLQSPLKMTNSPVLPVGSTTNGSRSSTPSPSPLNLSSSRNTQGYLYTAEGAQEEPQVEPLDLSLPKQQGELLERSTITSVYQNSVYSVQEEPLNLSCAKKEPQKDSCVTDSEPVVNVIPPSANPINIAIPTVTAQLPTIVAIADQNSVPCLRALAANKQTILIPQVAYTYSTTVSPAVQEPPLKVIQPNGNQDERQDTSSEGVSNVEDQNDSDSTPPKKKMRKTENGMYACDLCDKIFQKSSSLLRHKYEHTGKRPHECGICKKAFKHKHHLIEHMRLHSGEKPYQCDKCGKRFSHSGSYSQHMNHRYSYCKREAEERDSTEQEEAGPEILSNEHVGARASPSQGDSDERESLTREEDEDSEKEEEEEDKEMEELQEEKECEKPQGDEEEEEEEEEVEEEEVEEAENEGEEAKTEGLMKDDRAESQASSLGQKVGESSEQVSEEKTNEA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
29PhosphorylationNYNTVVETNSDSDDE
CCCEEEECCCCCCCC
28.5430576142
31PhosphorylationNTVVETNSDSDDEDK
CEEEECCCCCCCCCC
46.0025159151
31 (in isoform 2)Phosphorylation-46.0027251275
33PhosphorylationVVETNSDSDDEDKLH
EEECCCCCCCCCCEE
46.9425159151
33 (in isoform 2)Phosphorylation-46.9427251275
46PhosphorylationLHIVEEESVTDAADC
EEEEEEEECCCHHHC
33.3330576142
48PhosphorylationIVEEESVTDAADCEG
EEEEEECCCHHHCCC
29.2430576142
48 (in isoform 2)Phosphorylation-29.2427251275
114PhosphorylationVKDDECESDAENEQN
ECCCCCCCCCCCCCC
54.5026471730
135PhosphorylationEFLQQQDTAVIFPEA
HHHHHCCCEEECCCC
20.6326074081
151PhosphorylationEEDQRQGTPEASGHD
HHHHCCCCCCCCCCC
15.0426074081
155PhosphorylationRQGTPEASGHDENGT
CCCCCCCCCCCCCCC
34.6928122231
162PhosphorylationSGHDENGTPDAFSQL
CCCCCCCCCCHHHHH
29.5828122231
167PhosphorylationNGTPDAFSQLLTCPY
CCCCCHHHHHHCCCC
22.9527080861
171PhosphorylationDAFSQLLTCPYCDRG
CHHHHHHCCCCCCCC
21.7427080861
174PhosphorylationSQLLTCPYCDRGYKR
HHHHCCCCCCCCCHH
14.7727080861
184PhosphorylationRGYKRFTSLKEHIKY
CCCHHHHHHHHHHHH
34.43-
186SumoylationYKRFTSLKEHIKYRH
CHHHHHHHHHHHHHH
47.1928112733
186UbiquitinationYKRFTSLKEHIKYRH
CHHHHHHHHHHHHHH
47.19-
195SumoylationHIKYRHEKNEDNFSC
HHHHHHHHCCCCCEE
60.5628112733
243PhosphorylationCNRKFKCTECGKAFK
CCCEEEECCCCHHHH
34.60-
263PhosphorylationKEHLRIHSGEKPYEC
HHHHEECCCCCCCCC
46.4028450419
278PhosphorylationPNCKKRFSHSGSYSS
CCCCCCCCCCCCCCC
22.3028555341
280PhosphorylationCKKRFSHSGSYSSHI
CCCCCCCCCCCCCCC
28.3928555341
282PhosphorylationKRFSHSGSYSSHISS
CCCCCCCCCCCCCCC
25.5128555341
283PhosphorylationRFSHSGSYSSHISSK
CCCCCCCCCCCCCCC
20.0930576142
284PhosphorylationFSHSGSYSSHISSKK
CCCCCCCCCCCCCCC
19.6930576142
285PhosphorylationSHSGSYSSHISSKKC
CCCCCCCCCCCCCCE
19.3330576142
288PhosphorylationGSYSSHISSKKCISL
CCCCCCCCCCCEEEE
30.59-
289PhosphorylationSYSSHISSKKCISLI
CCCCCCCCCCEEEEE
35.22-
304PhosphorylationPVNGRPRTGLKTSQC
ECCCEECCCCCCCCC
49.9323312004
307SumoylationGRPRTGLKTSQCSSP
CEECCCCCCCCCCCC
47.6928112733
308PhosphorylationRPRTGLKTSQCSSPS
EECCCCCCCCCCCCC
29.1321712546
309PhosphorylationPRTGLKTSQCSSPSL
ECCCCCCCCCCCCCC
27.8321712546
312PhosphorylationGLKTSQCSSPSLSAS
CCCCCCCCCCCCCCC
37.3321712546
313PhosphorylationLKTSQCSSPSLSASP
CCCCCCCCCCCCCCC
26.5723401153
313 (in isoform 2)Phosphorylation-26.5724719451
314 (in isoform 2)Phosphorylation-24.0127251275
315PhosphorylationTSQCSSPSLSASPGS
CCCCCCCCCCCCCCC
36.5821712546
317PhosphorylationQCSSPSLSASPGSPT
CCCCCCCCCCCCCCC
30.9121712546
319PhosphorylationSSPSLSASPGSPTRP
CCCCCCCCCCCCCCH
26.8125159151
322PhosphorylationSLSASPGSPTRPQIR
CCCCCCCCCCCHHHH
26.8725159151
323 (in isoform 2)Phosphorylation-38.0424719451
324PhosphorylationSASPGSPTRPQIRQK
CCCCCCCCCHHHHHH
57.5922617229
331SumoylationTRPQIRQKIENKPLQ
CCHHHHHHHHCCCHH
41.9828112733
335SumoylationIRQKIENKPLQEQLS
HHHHHHCCCHHHCCC
34.0228112733
335UbiquitinationIRQKIENKPLQEQLS
HHHHHHCCCHHHCCC
34.02-
342PhosphorylationKPLQEQLSVNQIKTE
CCHHHCCCCCCCCCC
20.7925159151
343 (in isoform 2)Phosphorylation-9.2127251275
347SumoylationQLSVNQIKTEPVDYE
CCCCCCCCCCCCCCC
36.75-
347SumoylationQLSVNQIKTEPVDYE
CCCCCCCCCCCCCCC
36.7528112733
439SumoylationNQANLASKEQETINA
CCHHCCCCCHHCCCC
58.7828112733
443PhosphorylationLASKEQETINASPIQ
CCCCCHHCCCCCCCC
21.1630108239
447PhosphorylationEQETINASPIQQGGH
CHHCCCCCCCCCCCE
20.3230108239
455PhosphorylationPIQQGGHSVISAISL
CCCCCCEEEEEEEEC
25.1530108239
458PhosphorylationQGGHSVISAISLPLV
CCCEEEEEEEECEEE
19.8630108239
461PhosphorylationHSVISAISLPLVDQD
EEEEEEEECEEECCC
24.5330108239
470PhosphorylationPLVDQDGTTKIIINY
EEECCCCCEEEEEEE
32.9527080861
471PhosphorylationLVDQDGTTKIIINYS
EECCCCCEEEEEEEE
26.2727080861
493SumoylationQVVPQNLKKENPVAT
EECCCCCCCCCCCCC
66.64-
493SumoylationQVVPQNLKKENPVAT
EECCCCCCCCCCCCC
66.6428112733
504SumoylationPVATNSCKSEKLPED
CCCCCCCCCCCCCCC
62.56-
504SumoylationPVATNSCKSEKLPED
CCCCCCCCCCCCCCC
62.5628112733
504UbiquitinationPVATNSCKSEKLPED
CCCCCCCCCCCCCCC
62.56-
507UbiquitinationTNSCKSEKLPEDLTV
CCCCCCCCCCCCCCC
76.16-
515SumoylationLPEDLTVKSEKDKSF
CCCCCCCCCCCCCCC
47.89-
515SumoylationLPEDLTVKSEKDKSF
CCCCCCCCCCCCCCC
47.8928112733
515UbiquitinationLPEDLTVKSEKDKSF
CCCCCCCCCCCCCCC
47.89-
516PhosphorylationPEDLTVKSEKDKSFE
CCCCCCCCCCCCCCC
45.6121712546
521PhosphorylationVKSEKDKSFEGGVND
CCCCCCCCCCCCCCC
38.3730576142
529PhosphorylationFEGGVNDSTCLLCDD
CCCCCCCCCEEEECC
18.8030576142
530PhosphorylationEGGVNDSTCLLCDDC
CCCCCCCCEEEECCC
15.2727732954
548SumoylationINALPELKHYDLKQP
CCCCCCCCCCCCCCC
38.1628112733
553SumoylationELKHYDLKQPTQPPP
CCCCCCCCCCCCCCC
51.8628112733
571PhosphorylationAEAEKPESSVSSATG
HHCCCCCCCCCCCCC
44.5623663014
572PhosphorylationEAEKPESSVSSATGD
HCCCCCCCCCCCCCC
25.1023663014
574PhosphorylationEKPESSVSSATGDGN
CCCCCCCCCCCCCCC
19.0623663014
575PhosphorylationKPESSVSSATGDGNL
CCCCCCCCCCCCCCC
27.9123663014
576 (in isoform 2)Phosphorylation-14.2227251275
577PhosphorylationESSVSSATGDGNLSP
CCCCCCCCCCCCCCC
37.4423663014
583PhosphorylationATGDGNLSPSQPPLK
CCCCCCCCCCCCCHH
26.8925159151
585PhosphorylationGDGNLSPSQPPLKNL
CCCCCCCCCCCHHHH
52.5223663014
594PhosphorylationPPLKNLLSLLKAYYA
CCHHHHHHHHHHHHH
34.5224719451
613UbiquitinationPSAEELSKIADSVNL
CCHHHHHHHHHHCCC
55.31-
638PhosphorylationKMQAGQISVQSSEPS
HHHCCCCEEECCCCC
13.2522115753
641PhosphorylationAGQISVQSSEPSSPE
CCCCEEECCCCCCCC
34.2225159151
642PhosphorylationGQISVQSSEPSSPEP
CCCEEECCCCCCCCC
36.1125159151
642 (in isoform 2)Phosphorylation-36.1127251275
645PhosphorylationSVQSSEPSSPEPGKV
EEECCCCCCCCCCCC
55.2425159151
646PhosphorylationVQSSEPSSPEPGKVN
EECCCCCCCCCCCCC
43.9525159151
646 (in isoform 2)Phosphorylation-43.9527251275
664PhosphorylationKNNDQPQSANANEPQ
CCCCCCCCCCCCCCC
30.1223403867
673PhosphorylationNANEPQDSTVNLQSP
CCCCCCCCCCCCCCC
29.0730266825
674PhosphorylationANEPQDSTVNLQSPL
CCCCCCCCCCCCCCC
23.0030266825
679PhosphorylationDSTVNLQSPLKMTNS
CCCCCCCCCCCCCCC
35.0525159151
680 (in isoform 2)Phosphorylation-24.0427251275
684PhosphorylationLQSPLKMTNSPVLPV
CCCCCCCCCCCEECC
30.8430108239
686PhosphorylationSPLKMTNSPVLPVGS
CCCCCCCCCEECCCC
13.7625159151
693PhosphorylationSPVLPVGSTTNGSRS
CCEECCCCCCCCCCC
32.0930576142
694PhosphorylationPVLPVGSTTNGSRSS
CEECCCCCCCCCCCC
20.5319690332
695PhosphorylationVLPVGSTTNGSRSST
EECCCCCCCCCCCCC
39.0019690332
698PhosphorylationVGSTTNGSRSSTPSP
CCCCCCCCCCCCCCC
30.9330576142
699 (in isoform 2)Phosphorylation-35.7027251275
700PhosphorylationSTTNGSRSSTPSPSP
CCCCCCCCCCCCCCC
40.0225159151
701PhosphorylationTTNGSRSSTPSPSPL
CCCCCCCCCCCCCCC
43.1325159151
702PhosphorylationTNGSRSSTPSPSPLN
CCCCCCCCCCCCCCC
29.0925159151
704PhosphorylationGSRSSTPSPSPLNLS
CCCCCCCCCCCCCCC
37.7925159151
706PhosphorylationRSSTPSPSPLNLSSS
CCCCCCCCCCCCCCC
46.4822617229
711PhosphorylationSPSPLNLSSSRNTQG
CCCCCCCCCCCCCCC
25.7930576142
712PhosphorylationPSPLNLSSSRNTQGY
CCCCCCCCCCCCCCE
36.1630576142
713PhosphorylationSPLNLSSSRNTQGYL
CCCCCCCCCCCCCEE
26.6126074081
716PhosphorylationNLSSSRNTQGYLYTA
CCCCCCCCCCEEEEC
23.43-
774SumoylationPLNLSCAKKEPQKDS
CCCCCCCCCCCCCCC
63.09-
774SumoylationPLNLSCAKKEPQKDS
CCCCCCCCCCCCCCC
63.0928112733
848PhosphorylationVAYTYSTTVSPAVQE
EEEEEECCCCHHHCC
17.0427690223
850PhosphorylationYTYSTTVSPAVQEPP
EEEECCCCHHHCCCC
12.6827690223
873PhosphorylationNQDERQDTSSEGVSN
CCCCCCCCCCCCCCC
26.3030576142
874PhosphorylationQDERQDTSSEGVSNV
CCCCCCCCCCCCCCC
34.3830177828
875PhosphorylationDERQDTSSEGVSNVE
CCCCCCCCCCCCCCC
40.2330177828
879PhosphorylationDTSSEGVSNVEDQND
CCCCCCCCCCCCCCC
46.1230177828
887PhosphorylationNVEDQNDSDSTPPKK
CCCCCCCCCCCCCCH
40.8026657352
889PhosphorylationEDQNDSDSTPPKKKM
CCCCCCCCCCCCHHH
46.9220873877
890PhosphorylationDQNDSDSTPPKKKMR
CCCCCCCCCCCHHHC
48.9128985074
890 (in isoform 2)Phosphorylation-48.9127251275
917PhosphorylationDKIFQKSSSLLRHKY
HHHHHHCHHHHHHHC
31.8524719451
918PhosphorylationKIFQKSSSLLRHKYE
HHHHHCHHHHHHHCC
38.2124719451
918 (in isoform 2)Phosphorylation-38.2124719451
927PhosphorylationLRHKYEHTGKRPHEC
HHHHCCCCCCCCHHC
32.24-
955PhosphorylationIEHMRLHSGEKPYQC
HHHHHCCCCCCCCCC
53.9226055452
960PhosphorylationLHSGEKPYQCDKCGK
CCCCCCCCCCCCCCC
32.6127732954
970PhosphorylationDKCGKRFSHSGSYSQ
CCCCCCCCCCCCCHH
22.3025262027
972PhosphorylationCGKRFSHSGSYSQHM
CCCCCCCCCCCHHHH
28.3925262027
974PhosphorylationKRFSHSGSYSQHMNH
CCCCCCCCCHHHHCH
25.3225262027
975PhosphorylationRFSHSGSYSQHMNHR
CCCCCCCCHHHHCHH
18.8425262027
976PhosphorylationFSHSGSYSQHMNHRY
CCCCCCCHHHHCHHH
18.4625262027
995PhosphorylationREAEERDSTEQEEAG
HHHHHCCCHHHHHHC
39.8130266825
996PhosphorylationEAEERDSTEQEEAGP
HHHHCCCHHHHHHCH
46.0830266825
1007PhosphorylationEAGPEILSNEHVGAR
HHCHHHHCCCCCCCC
45.9226074081
1016PhosphorylationEHVGARASPSQGDSD
CCCCCCCCCCCCCCH
21.3823663014
1018PhosphorylationVGARASPSQGDSDER
CCCCCCCCCCCCHHH
44.2820873877
1022PhosphorylationASPSQGDSDERESLT
CCCCCCCCHHHHHCC
48.4723663014
1027PhosphorylationGDSDERESLTREEDE
CCCHHHHHCCCCCCC
41.0623663014
1029PhosphorylationSDERESLTREEDEDS
CHHHHHCCCCCCCCH
45.3627732954
1036PhosphorylationTREEDEDSEKEEEEE
CCCCCCCHHHHHHHH
48.8228985074
1100PhosphorylationMKDDRAESQASSLGQ
CCCHHHHHHHHHHHH
30.0225159151
1103PhosphorylationDRAESQASSLGQKVG
HHHHHHHHHHHHHHC
20.6129978859
1104PhosphorylationRAESQASSLGQKVGE
HHHHHHHHHHHHHCC
39.2628387310
1108AcetylationQASSLGQKVGESSEQ
HHHHHHHHHCCCHHH
50.8626051181
1108UbiquitinationQASSLGQKVGESSEQ
HHHHHHHHHCCCHHH
50.86-
1112PhosphorylationLGQKVGESSEQVSEE
HHHHHCCCHHHHCHH
32.9929978859
1113PhosphorylationGQKVGESSEQVSEEK
HHHHCCCHHHHCHHH
27.9629978859
1117PhosphorylationGESSEQVSEEKTNEA
CCCHHHHCHHHHCCC
39.4729978859

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
585SPhosphorylationKinaseATMQ13315
PSP
-KUbiquitinationE3 ubiquitin ligaseFBXO45P0C2W1
PMID:25460509
-KUbiquitinationE3 ubiquitin ligaseSIAH1Q8IUQ4
PMID:25528765
-KUbiquitinationE3 ubiquitin ligaseSIAH2O43255
PMID:25528765

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ZEB1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ZEB1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NC2A_HUMANDRAP1physical
9418848
KAT5_HUMANKAT5physical
11275565
SMAD2_HUMANSMAD2physical
12743038
SMAD3_HUMANSMAD3physical
12743038
SMAD1_HUMANSMAD1physical
12743038
SMCA4_HUMANSMARCA4physical
20418909
SMAD6_HUMANSMAD6physical
20514018
SMAD7_HUMANSMAD7physical
20514018
CTBP1_HUMANCTBP1physical
10567582
CTBP2_HUMANCTBP2physical
10567582
EP300_HUMANEP300physical
12743039
CTBP2_HUMANCTBP2physical
25086746
CTBP1_HUMANCTBP1physical
25086746
SIR1_HUMANSIRT1physical
25086746
UBP7_HUMANUSP7physical
25086746
CHK1_HUMANCHEK1physical
25086746
ATM_HUMANATMphysical
25086746
MPP8_HUMANMPHOSPH8physical
25870236
SIR1_HUMANSIRT1physical
25870236
UBP7_HUMANUSP7physical
29119051
UBP10_HUMANUSP10physical
29119051
UBP13_HUMANUSP13physical
29119051
UBP26_HUMANUSP26physical
29119051
UBP29_HUMANUSP29physical
29119051
UBP51_HUMANUSP51physical
29119051
PAN2_HUMANPAN2physical
29119051
UBP53_HUMANUSP53physical
29119051
UCHL3_HUMANUCHL3physical
29119051
VCIP1_HUMANVCPIP1physical
29119051

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
609141Corneal dystrophy, posterior polymorphous, 3 (PPCD3)
613270Corneal dystrophy, Fuchs endothelial, 6 (FECD6)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ZEB1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-642; SER-679 ANDTHR-702, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-583; SER-646; THR-702AND SER-704, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-322 AND SER-646, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31 AND SER-33, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-679, AND MASSSPECTROMETRY.
Sumoylation
ReferencePubMed
"Pc2-mediated sumoylation of Smad-interacting protein 1 attenuatestranscriptional repression of E-cadherin.";
Long J., Zuo D., Park M.;
J. Biol. Chem. 280:35477-35489(2005).
Cited for: SUMOYLATION AT LYS-347 AND LYS-774.

TOP